Cynosure Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $409K | Buy |
17,820
+5,419
| +44% | +$124K | 0.05% | 267 |
|
2025
Q1 | $360K | Buy |
12,401
+4,783
| +63% | +$139K | 0.05% | 202 |
|
2024
Q4 | $283K | Buy |
7,618
+192
| +3% | +$7.13K | 0.04% | 320 |
|
2024
Q3 | $360K | Sell |
7,426
-1,850
| -20% | -$89.8K | 0.05% | 323 |
|
2024
Q2 | $371K | Buy |
9,276
+2,022
| +28% | +$80.9K | 0.06% | 284 |
|
2024
Q1 | $319K | Buy |
+7,254
| New | +$319K | 0.06% | 249 |
|